Authors:
DELVA R
GAMELIN E
LORTHOLARY A
MAILLART P
DELAJARRIGE PL
GIRAULT C
GUERIN J
LARRA F
Citation: R. Delva et al., SUPPRESSION OF HEPARINIZATION OF CENTRAL VENOUS CATHETERS BETWEEN CYCLES OF CHEMOTHERAPY - RESULTS OF A PHASE-I STUDY, Supportive care in cancer, 6(4), 1998, pp. 384-388
Authors:
DELVA R
LORTHOLARY A
GAMELIN E
MAILLART P
GUERIN O
LEYNIA P
BIVILLE F
LARRA F
Citation: R. Delva et al., EFFICACY OF CHEMOTHERAPY(CT) ADAPTATION ACCORDING TO PATHOLOGICAL RESPONSE AFTER PRIMARY CHEMOTHERAPY (PCT) FOR LOCALLY ADVANCED BREAST-CANCER (LABC), Annals of oncology, 9, 1998, pp. 600-600
Authors:
GAMELIN E
BOISDRONCELLE M
DELVA R
REGIMBEAU C
CAILLEUX PE
ALLEAUME C
MAILLET ML
GOUDIER MJ
SIRE M
PERSONJOLY MC
MAIGRE M
MAILLART P
FETY R
BURTIN P
LORTHOLARY A
DUMESNIL Y
PICON L
GESLIN J
GESTA P
DANQUECHINDORVAL E
LARRA F
ROBERT J
Citation: E. Gamelin et al., LONG-TERM WEEKLY TREATMENT OF COLORECTAL METASTATIC CANCER WITH FLUOROURACIL AND LEUCOVORIN - RESULTS OF A MULTICENTRIC PROSPECTIVE TRIAL OF FLUOROURACIL DOSAGE OPTIMIZATION BY PHARMACOKINETIC MONITORING IN 152 PATIENTS, Journal of clinical oncology, 16(4), 1998, pp. 1470-1478
Authors:
GAMELIN E
LEBOUIL A
BOISDRONCELLE M
TURCANT A
DELVA R
CAILLEUX A
KRIKORIAN A
BRIENZA S
CVITKOVIC E
ROBERT J
LARRA F
ALLAIN P
Citation: E. Gamelin et al., CUMULATIVE PHARMACOKINETIC STUDY OF OXALIPLATIN, ADMINISTERED EVERY 3WEEKS, COMBINED WITH 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS, Clinical cancer research, 3(6), 1997, pp. 891-899
Authors:
MEYER V
DELVA R
GAMELIN E
LAMEZEC B
MAILLART P
DANQUECHINDORVAL E
LORTHOLARY A
BOISDRONCELLE M
MAIGRE M
BRIENZA S
CVITKOVIC E
LARRA F
Citation: V. Meyer et al., OXALIPLATIN (LOHP) AND 5-FLUOROURACIL (5-FU) SYNERGISM IN ADVANCED COLORECTAL-CANCER PATIENTS (ACRC), European journal of cancer, 33, 1997, pp. 746-746
Authors:
DELVA R
MEGE M
GAMELIN E
MAILLART P
LORTHOLARY A
GUERIN O
PEIN F
LARRA F
Citation: R. Delva et al., PRESENTATION OF THE DOSE-INTENSITY FROM A N ASSOCIATION CARBOPLATIN-CYCLOPHOSPHAMIDE-ETOPOSID FOR WOMEN OLDER THAN 70 PRESENTING AN OVARIAN-CARCINOMA, Bulletin du cancer, 83(1), 1996, pp. 63-69
Authors:
BOUGNOUX P
DELVA R
SERIN D
NAMER M
PIOT G
LOTZ JP
RAMEE JF
VUILLEMIN E
GRAU B
ROUBINET A
SOARES JA
CHAZARD M
Citation: P. Bougnoux et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT C-CSF ASA 2ND-LINE THERAPY IN PATIENTS PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 378-378
Authors:
GAMELIN E
DELVA R
DUMASNIL Y
JACOB J
MAILLART P
CALLE MB
GOUDIER MJ
LORTHOLARY A
HARDOUIN A
GESLIN J
HETROY J
LARRA F
Citation: E. Gamelin et al., HIGH-DOSE 5FU BIOMODULATION BY HIGH-DOSE LEUCOVORIN AND INDIVIDUAL 5FU DOSE ADJUSTMENT IN METASTATIC COLORECTAL-CANCER - A MULTICENTRIC PROSPECTIVE-STUDY OF 130 PATIENTS, European journal of cancer, 31A, 1995, pp. 729-729
Authors:
MAILLART P
LORIMIER G
GAMELIN E
DELVA R
LORTHOLARY A
MEYER V
GUERIN J
GIRAUD C
LARRA F
Citation: P. Maillart et al., TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES (TTVAD) IN CANCEROLOGY - RESULTS OF 141 PERCUTANEOUS CANNULATION, European journal of cancer, 31A, 1995, pp. 892-892
Authors:
DELVA R
LEYNIA P
GAMELIN E
LORTHOLARY A
MAILLART P
GUERIN O
LARRA F
Citation: R. Delva et al., CLINICAL AND ECONOMICAL EFFICACY FROM A NEW DECISION TREE FOR THE USEOF ANTIEMETIC TREATMENTS, European journal of cancer, 31A, 1995, pp. 1232-1232
Authors:
GAMELIN E
ALLAIN P
MAILLART P
TURCANT A
DELVA R
LORTHOLARY A
LARRA F
Citation: E. Gamelin et al., LONG-TERM PHARMACOKINETIC BEHAVIOR OF PLATINUM AFTER CISPLATIN ADMINISTRATION, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 97-102
Authors:
MAILLART P
LORIMIER G
MEYER V
GUERIN J
GIRAUD C
GAMELIN E
DELVA R
LORTHOLARY A
Citation: P. Maillart et al., IMPLANTABLE SITES IN CANCEROLOGY - THE PE RCUTANEOUS TECHNIQUE - A HOMOGENEOUS SERIES OF 141 CASES, Journal de chirurgie, 132(12), 1995, pp. 495-498